Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Cambridge, MA
SEC filing record 1 source field available
Fiscal year end
31 December
Spero Therapeutics, Inc. has filed 506 SEC EDGAR filings since 21 Mar 2017

SEC filing history

Showing 376-400 of 506 matching filings.

Per page
25
Current page
16
4

FORM 4 SUBMISSION

Filing date
05 Jun 2019
Reporting date
05 Jun 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
05 Jun 2019
Reporting date
05 Jun 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
05 Jun 2019
Reporting date
05 Jun 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
05 Jun 2019
Reporting date
05 Jun 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
05 Jun 2019
Reporting date
05 Jun 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
05 Jun 2019
Reporting date
05 Jun 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38266

8-K

Filing date
09 May 2019
Reporting date
09 May 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-38266

DEF 14A

Filing date
26 Apr 2019
Reporting date
05 Jun 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38266

8-K

Filing date
18 Apr 2019
Reporting date
18 Apr 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
CT ORDER File 001-38266

CT ORDER filing

Filing date
01 Apr 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
29 Mar 2019
Reporting date
29 Mar 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K/A File 001-38266

FORM 8-K/A

Filing date
29 Mar 2019
Reporting date
19 Mar 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
19 Mar 2019
Reporting date
19 Mar 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38266

8-K

Filing date
19 Mar 2019
Reporting date
19 Mar 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-230283

S-8

Filing date
14 Mar 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-230281

S-8

Filing date
14 Mar 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38266

8-K

Filing date
14 Mar 2019
Reporting date
14 Mar 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-90168

SC 13G/A

Filing date
14 Feb 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-90168

AMENDMENT NO. 1 TO THE SCHEDULE 13G

Filing date
14 Feb 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-90168

SC 13G/A

Filing date
14 Feb 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-90168

SC 13G/A filing

Filing date
13 Feb 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-90168

SC 13G/A

Filing date
08 Feb 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38266

FORM 8-K

Filing date
07 Jan 2019
Reporting date
04 Jan 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .